Bixiye
QP9-18 New Drug-Related Pharmacy Step Therapy (ST) Program Ophthalmic Antihistamine
Taariikhda uu dhaqangalayo Barnaamijka: 05, Feb 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2901 - 2910 ee natiijooyinka 3167
Bixiye
QP8-18 Effective January 1, 2018 FEP Standard Option Subscriber SNF Benefit
Taariikhda uu dhaqangalayo Barnaamijka: 05, Feb 2018
Bixiye
P7-18 Addition of Drug to the Doxycycline and Minocycline PA Program
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2018
Bixiye
P6-18 Addition of Drug to the Self-Administered Oncology PA with QL Program
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2018
Bixiye
P5-18 New Medical Drug-Related PA Requirements for Yescarta and Kymriah
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2018
Bixiye
P4-18 Changes to Medical Policy IV-126 Sacroiliac Joint Fusion
Taariikhda uu dhaqangalayo Barnaamijka: Jan 24, 2018
Bixiye
P3-18 New Drug-Related PA Criteria: Inhaled Antibiotics Duplicate Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Jan 24, 2018
Bixiye
QP7-18 Disclosure of Ownership Form
Taariikhda uu dhaqangalayo Barnaamijka: Jan 18, 2018
Bixiye
QP6-18 Updated Commercial PA Request Form and PA List for Early Intensive Behavioral Intervention Services
Taariikhda uu dhaqangalayo Barnaamijka: Jan 17, 2018
Bixiye
QP5-18 Quality Initiatives at Blue Cross
Taariikhda uu dhaqangalayo Barnaamijka: Jan 16, 2018